Tag:
Leukemia & Lymphoma Society
Latest Headlines
Latest Headlines
Curis gets $4M for blood cancer therapy
The Leukemia & Lymphoma Society (LLS) has handed Lexington, MA-based Curis $4 million to support early development of two of the company's drugs for blood cancers. Curis' drug, CUDC-907, is an
Avila teams with Leukemia & Lymphoma Society on early-stage cancer trial
The Leukemia & Lymphoma Society knows how to be patient. Over the last 50 years it's backed hundreds of basic academic research projects on blood cancers, many of which required 15 or 20 or 25
